These findings indicate that shChREBP treatment in acute hepatic GSD Ib increases hepatic G6P and glycogen accumulation in parallel to hypoglycemia-associated changes in plasma glucagon-to-insulin ratios, and corresponding changes in free fatty acid and ketone body levels. This evidence concerns the gene GCG and Hypoglycemia.